NCT04152551View on ClinicalTrials.gov

Effects of Bisphosphonates on OI-Related Hearing Loss

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 2, 2019

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Osteogenesis Imperfecta
Interventions
DRUG

Risedronate Oral Tablet

Oral bisphosphonate

Trial Locations (1)

10021

RECRUITING

Hospital for Special Surgery, New York

Sponsors
All Listed Sponsors
collaborator

The New York Community Trust

OTHER

collaborator

East River Medical Imaging

UNKNOWN

collaborator

Northwell Health

OTHER

lead

Hospital for Special Surgery, New York

OTHER

NCT04152551 - Effects of Bisphosphonates on OI-Related Hearing Loss | Biotech Hunter | Biotech Hunter